Weird Quantum Space, Space Eyes, Lucy In The Sky, Not Dead Yet, Old Genes, What The Frack?, Skin You're In, We All Gots Bugs, CRISPR Cures Hemophilia, Boiling Water, Life Choices, And Much More!!!
NYS Entity Status
NYS Filing Date
FEBRUARY 14, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2013 - FUSION PHYSICAL THERAPY WELLNESS P.C.
Around the Web
- 30 November, 2016 – Episode 595 – This Week in Science Podcast (TWIS)
By Kirsten Sanford - Thursday Dec 1, 2016
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- The Rebuilding Years, Post-Sandy
By THE NEW YORK TIMES and JONAH MARKOWITZ - Sunday Oct 29, 2017
Those affected by Hurricane Sandy five years ago shared how the storm changed their lives physically, emotionally and financially, and how things have changed for the better since.
- NY insurance company dragged into Wells Fargo scandal
By Kevin Dugan - Tuesday Aug 1, 2017
The New York insurance company that wrote policies for 800,000 questionable Wells Fargo auto loans has been dragged into the bank’s latest scandal. National General Insurance was named in a class-action lawsuit filed against the bank — for allegedly unduly profiting from $80 million in collateral protection insurance that the drivers didn’t need — and...
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]